Peptone 2025

Intrinsically disordered proteins (IDPs)—where classical structural biology reaches its limits—are where Peptone begins its work.

Peptone develops novel small-molecule therapeutics targeting disease-causing IDPs, which cannot be modeled by AlphaFold 3. Their state-of-the-art mass spectrometry system, designed specifically for IDPs, unveils previously inaccessible insights into IDP characteristics. By integrating physics, molecular biology, and next-generation supercomputing models, Peptone transforms spectrometry data into small-molecule designs within weeks.

On the 21.03 we had an exclusive behind-the-scenes look at Peptone’s laboratory in Bellinzona and met their pioneering team of protein engineers, molecular biologists, and formulation experts.​